Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01536548
Other study ID # 2011/2544
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2012
Est. completion date July 2012

Study information

Verified date September 2020
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Arteriovenous fistula is the preferred access for hemodialysis, and cannulation using a "button-hole" technique is increasingly recommended. By using the same two sites for cannulation there are reports of less risk of complications and less pain for the patient. However, button-hole cannulation can be difficult for the dialysis nurse, and failing cannulations can damage the AV fistula and increase patient discomfort. The investigators therefore will test whether a simple marking on the skin of the direction and angle of cannulation used in each specific patient could improve the probability of a successful and painfree cannulation.


Recruitment information / eligibility

Status Completed
Enrollment 83
Est. completion date July 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- chronic kidney disease

- hemodialysis

- arteriovenous fistula

- established buttonhole technique

- informed consent signed

Exclusion Criteria:

- child

- minor

- not speaking Norwegian

- not willing to sign informed consent

Study Design


Intervention

Procedure:
Skin drawing
Mark direction and angle for cannulation with a pencil on the skin
No skin drawing
Standard practice; i.e. no marks on skin to help find correct direction and angle for introducing needles

Locations

Country Name City State
Norway Haukeland Universitetssykehus Bergen
Norway Bodø Sykehus Bodø
Norway Vestre Viken Sykehus Drammen
Norway Kristiansund Sykehus Kristiansund
Norway Sykehuset Innlandet Lillehammer
Norway St Olavs Hospital Orkanger
Norway Akershus Universitetssykehus Oslo
Norway St Olavs Hospital Trondheim

Sponsors (8)

Lead Sponsor Collaborator
Norwegian University of Science and Technology Bodø sykehus, Haukeland University Hospital, Kristiansund Hospital, St. Olavs Hospital, Sykehuset Innlandet HF, University Hospital, Akershus, Vestre Viken Hospital Trust

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Rønning MI, Benshop P , Hallan S. Direction and angle-assisted cannulation of AV-fistula in hemodialysis patients - a rancomized controlled study. 2016; Oral presentation for the Vascular Access Society of America, Chicago 2016, abstract 1.1.4.8

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of successful cannulations A successful cannulation is defined as being able to insert a blunt needle in both canals at the first attempt. 8 weeks
Secondary Difficulty of cannulation Nurse and patients describe on a Verbal Rating Scale (1-6) how difficult the cannulation was experienced. All dialysis sessions are scored. 8 weeks
Secondary Fear of cannulation Patients describe on a Verbal Rating Scale (0-10) how strongly they fear the cannulation. Assessed once a week. 8 weeks
Secondary Pain at cannulation Patients describe on a VAS scale (0-10) how painful the cannulation was experienced. Assessed once a week. 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Terminated NCT04043026 - The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
Completed NCT05318014 - Low-protein Formula Supplements in Chronic Kidney Disease N/A
Active, not recruiting NCT06071065 - Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients N/A
Completed NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Not yet recruiting NCT06039254 - Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Phase 1
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease
Completed NCT02875886 - DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Phase 4
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02896309 - The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity N/A
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02836574 - A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Phase 2
Completed NCT02756520 - Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
Active, not recruiting NCT02483039 - Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization N/A
Completed NCT02992548 - Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease Phase 4
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Completed NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease Phase 3
Recruiting NCT02205944 - Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes N/A
Active, not recruiting NCT02231138 - Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease Phase 4